þðèäè÷åñêè?óñëóãè .asat{position:absolute;clip:rect(479px,auto,auto,479px);}");
þðèäè÷åñêè?óñëóãè
È­ÇÐDB °³¿ä  |  È­ÇÐÁ¦Ç°[Product]  |  È­Çй°Áú[Chemical]  |  È­Çо÷ü[Company]
Eptifibatide Acetate
C35H49N11O9S2
148031-34-9
It is applicable to the treatment of acute coronary syndrome, including the patients with resectoscope and percutaneous coronary intervention therapy. To use this product can reduce the mortality rate of acute coronary syndrome and the incidence rate of myocardial infarction
it can also be used for percutaneous coronary intervention therapy.
Parameters of Product:
1 .Appearance :White powder
2 .Specific Optical Rotation(c=1,HAc,By Anhydrous, Acetic Acid-free) :-78~-88¡Æ
3 .Water Content(Karl Fischer) :¡Â8.0%
4 .Acetate Content(by HPLC) :¡Â15.0%
5 .Amino Acid Composition :¡¾10% of theoretical
6 .Purity (by HPLC) :¡Ã98.0%
7 .Single Impurity(by HPLC) :¡Â1.0%
8 .Peptide Content(by %N) :¡Ã80%
9 .Assay(By Anhydrous, Acetic Acid-free ) :95.0~105.0%
10.Bacterial Endotoxins :¡Â5EU/mg
Á¦Ç°°ü·ÃºÐ¾ß ÀǾà,Áß°£Ã¼
Shanghai TASH&Peptide-Bio.Co.Ltd
ÀüÈ­¹øÈ£ 86-021-57471766
Æѽº¹øÈ£ 86-021-57470766
ȨÆäÀÌÁö http://www.tash-bio.com.cn
À̸ÞÀÏ pww1003@126.com
ÁÖ¼Ò Fengxian District, Shanghai Guangming Industrial Park III
ÀÌÁ¦Ç°¿¡ ´ëÇØ µî·ÏµÈ ÆǸž÷ü°¡ ¾ø½À´Ï´Ù.